Report Categories

The global Sirolimus Eluting Coronary Stent market size is expected to reach $ 132.2 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent market size was valued at USD 105 million in 2023 and is forecast to a readjusted size of USD 132.2 million by 2030 with a CAGR of 3.3% during review period.

USD3480.00

Add To Cart

The global Sirolimus Eluting Coronary Stent System market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent System market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

A bioabsorbable sirolimus-eluting coronary stent system is an advanced medical device used to treat narrowed or blocked coronary arteries. This system consists of a stent made from bioabsorbable materials and coated with sirolimus, a drug that helps to inhibit restenosis. Once implanted into the coronary artery, the stent provides mechanical support to keep the vessel open, while the sirolimus coating gradually releases the drug to inhibit endothelial cell proliferation, reducing the risk of restenosis. Over time, the bioabsorbable stent is gradually absorbed by the body, reducing the complications associated with long-term implantation and allowing the vessel to return to its natural function.

USD3480.00

Add To Cart

A bioabsorbable sirolimus-eluting coronary stent system is an advanced medical device used to treat narrowed or blocked coronary arteries. This system consists of a stent made from bioabsorbable materials and coated with sirolimus, a drug that helps to inhibit restenosis. Once implanted into the coronary artery, the stent provides mechanical support to keep the vessel open, while the sirolimus coating gradually releases the drug to inhibit endothelial cell proliferation, reducing the risk of restenosis. Over time, the bioabsorbable stent is gradually absorbed by the body, reducing the complications associated with long-term implantation and allowing the vessel to return to its natural function.

USD4480.00

Add To Cart

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD3480.00

Add To Cart

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD4480.00

Add To Cart

The global Sirolimus Eluting Coronary Stent market size is expected to reach $ 132.2 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent market size was valued at USD 105 million in 2022 and is forecast to a readjusted size of USD 132.2 million by 2029 with a CAGR of 3.3% during review period.

USD3480.00

Add To Cart